Diagnosis and management of dengue

BMJ (Online)

Volumn 339, Issue 7731, 2009, Pages 1189-1193

  Teixeira, Maria Glória ^a   Barreto, Mauricio L ^a  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIPYRETIC AGENT; DENGUE VACCINE; ORAL REHYDRATION SOLUTION;

BLOOD TRANSFUSION; CLINICAL FEATURE; CLINICAL TRIAL; DENGUE; DENGUE VIRUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; DISEASE TRANSMISSION; ENDEMIC DISEASE; FLUID THERAPY; GASTROINTESTINAL HEMORRHAGE; HEALTH CARE SYSTEM; HEMORRHAGIC FEVER; HUMAN; MORTALITY; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION;

DENGUE; DENGUE HEMORRHAGIC FEVER; DIAGNOSIS, DIFFERENTIAL; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; EPIDEMIOLOGIC METHODS; HUMANS; NERVOUS SYSTEM DISEASES; PRACTICE GUIDELINES AS TOPIC; WORLD HEALTH;

EID: 71249094270     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4338     Document Type: Review

References (35)

1. World Health Organization. Dengue net. 2009. http://apps.who.int/ globalatlas/default.asp
2. World Health Organization. Impact of dengue. 2009. www.who.int/csr/ disease/dengue/impact/en/index.html.
3. Halstead SB, Dengue in the Americas and Southeast Asia: do they differ? Rev Panam Salud Publica 2006;6:407-415
4. Teixeira MG, Costa MCN, Barreto F, Barreto ML. Dengue: twenty-five years since reemergence in Brazil. Cad Saúde Pública 2009;25(suppl 1):S7-18.
5. Teixeira MG, Costa MCN, Coelho G, Barreto M. Recent shift in age pattern of dengue hemorrhagic fever, Brazil. Emerg Infect Dis 2008;14:1663.
6. Beasley DW, Barrett ADT. The infectious agent. In: Halstead SB, ed. Dengue: tropical medicine. Vol 5. Imperial College Press, 2008: 29-73.
7. Cohen SN, Halstead SB. Shock associated with dengue infection. I: clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J Pediatr 1966;68:448-456
8. Technical Advisory Committee (TAC) on DHF for SE Asia and Western Pacific regions (World Health Organization). Guides for diagnosis, treatment, surveillance, prevention and control of dengue haemorrhagic fever. Technical Report Series. Geneva: WHO, 1975.
9. World Health Organization. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: WHO, 1997.
10. Kittigul L, Pitakarnjanakul P, Sujirarat D, Siripanichgon K. The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J Clin Virol 2007;39(2):76-81. (Pubitemid 46777437)
11. Mairuhu ATA, MacGillavry MR, Setiati TE, Soemantri A, Cate H ten, Brandjes DPM, et al. Is clinical outcome of dengue-virus infections influenced by coagulation and fibrinolysis? A critical review of the evidence. Lancet Infect Dis 2003;3(1):33-41. (Pubitemid 36041788)
12. Kabra SK, Jain Y, Pandey RM, Madhulika, Singhal T, Tripathi P, et al. Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 1999;93:294-298
13. Harris E, Videa E, Perez L, Sandoval E, Téllez Y, Pérez ML, et al. Clinical, epidemiologic and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000;63(1):5-11.
14. Chairulfatah A, Setiabudi D, Ridad A, Colebunders R. Clinical manifestations of dengue haemorrhagic fever in children in Bandung, Indonesia. Ann Soc Belg Med Trop 1995;75:291-295
15. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, et al. Neurological manifestations of dengue infection. Lancet 2000;355:1053-1059
16. Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am J Trop Med Hyg 2001;65:848-851
17. Dussart P, Labeau B, Lagathu G, Louis P, Nunes MR, Rodrigues SG, et al. Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol 2006;13:1185-1189 (Pubitemid 46768874)
18. Vazquez S, Hafner G, Ruiz D, Calzada N, Guzman MG. Evaluation of immunoglobulin M and G capture enzyme-linked immunosorbent assay Panbio kits for diagnostic dengue infections. J Clin Virol 2007;39:194-198 (Pubitemid 46908966)
19. Souza VA, Tateno AF, Oliveira RR, Dominguesb RB, Araujo ES, Kuster GW, et al. Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection. J Clin Virol 2007;39:230-233
20. Endy TP, Nisalak A, Vaughn DW. Diagnosis of dengue virus infections. In: Halstead SB, ed. Dengue: tropical medicine. Vol 5. Imperial College Press, 2008:327-360
21. Morens DM, Halstead SB. The association between dengue hemorrhagic fever and second dengue infections is simply coincidental [controversies]. In: Halstead SB, ed. Dengue: tropical medicine. Vol 5. Imperial College Press, 2008:436-439
22. Rosen L. La pathogenèse de la dengue hemorragique: discussion critique des hypothèses Actuelles. Bull Soc Pathol 1986;79:342-349
23. Sierra BC, Koury G, Guzmán MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol 2007;152:533-542 (Pubitemid 46363592)
24. Cunha RV, Schatzmayr HG, Miagostovich MP, Barbosa AMA, Paiva FG, Miranda RMO, et al. Dengue epidemic in the State of Rio Grande do Norte, Brazil, 1997. Trans R Soc Trop Med Hyg 1999;93:247-249
25. Blanton RE, Silva LK, Morato VG, Parrado AR, Dias JP, Melo PR, et al. Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population. Eur J Hum Genet 2008;13:15-18
26. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987;18:392-397
27. Smart K, Safitri I. Evidence behind the WHO guidelines: hospital care for children: what treatments are effective for the management of shock in severe dengue? J Trop Pediatr 2009;55:145-148
28. Ngo NT, Cao XTP, Kneen R, Wills B, Nguyen VM, Nguyen TQ, et al. Acute management of dengue shock syndrome: a randomized double blind comparison of 4 intravenous fluid regimens in the first hour. Clin Infect Dis 2001;32:204-213 (Pubitemid 32524789)
29. Ranjit S, Kissoon N, Jayakumar I. Aggressive management of dengue shock syndrome may decrease mortality rate: a suggestive protocol. Pediatr Crit Care Med 2005;6:412-419
30. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877-889 (Pubitemid 41247927)
31. Halstead SB. Dengue vaccines are coming: are we prepared? Virus reviews and research. Socied Bras Virol 2008;13:29-30.
32. Ooi EE, Goh KT, Gubler DJ. Dengue prevention and 35 years of vector control in Singapore. Emerg Infect Dis 2006;12:887-893
33. Vanlerberghe V, Toledo ME, Rodríguez M, Gomez D, Baly A, Benitez JR, et al. Community involvement in dengue vector control: cluster randomised. BMJ 2009;338:1959b.
34. Kalayanarooj S. Standardized clinical management: evidence of reduction of dengue haemorrhagic fever case-fatality rate in Thailand. Dengue Bull 1999;23:10-17
35. Barreto ML, Teixeira MG. Dengue fever: a call for local, national and international actions [letter]. Lancet 2008;372:205.